J7634 Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram

Short descriptor: Budesonide comp con

✓ Active HCPCS Level II 2026
Open J7634 in the app →

Look up J7634 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J7634 is the HCPCS Level II code for Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2007-01-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
Budesonide, compounded product, administered through dme, concentrated form
Dose / Unit
per 0.25 milligram
Route
inhalation solution

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J7634 with the canonical source and edition:

J7634 — Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J7634

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J7634

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial